A cross-sectional survey of long-term outcomes for patients with diffuse capillary malformation with overgrowth To the Editor: Diffuse capillary malformation with overgrowth (DCMO) was recently described as a distinct subtype of vascular anomaly characterized by extensive capillary malformations (CMs) involving [1 anatomic region. 1 Most patients exhibit proportionate soft tissue or bony overgrowth that does not correlate with CM location or intensity. 1 Somatic mutations in GNA11 have been identified in DCMO, suggesting that aberrant mitogen-activated protein kinase signaling contributes to pathogenesis. 2 Because little is known about long-term outcomes in DCMO, we conducted a Boston Children's Hospital Institutional Review Boardeapproved anonymous REDCap survey. 3 Sixty-nine patients [5 years of age previously given a DCMO diagnosis and registered in the Vascular Anomalies Center database were contacted.
1 Thirty-one patients or parents of patients (45%) completed questionnaires about the vascular anomaly, overgrowth, and physical and psychological outcomes. Table I summarizes patient demographics. The mean age was 14.2 years. CMs were most commonly located on the posterior trunk and lower extremities, and overgrowth most frequently involved the extremities. Table II summarizes long-term outcomes. Nineteen of 31 (61%) patients, including 12 of the 13 with facial involvement, had laser therapy; 95% of the patients who had laser therapy reported response to treatment. Leg-length discrepancy (LLD) affected 19 of 31 (61%) patients; 63% of these individuals received treatments such as orthotics, surgical interventions, and physical therapy. Although no patient in the original cohort had true varicosities, 1 which would support an alternative diagnosis, 18 of 31 (58%) follow-up patients reported prominent veins or other venous abnormalities, including varicose veins, and 2 were treated with compression stockings or partial venectomy. No patient reported treatment for arm-length discrepancy, macrodactyly, or syndactyly; ability to perform daily tasks was largely unaffected.
We inquired about clinical features associated with other vascular anomalies that manifest over time (Table I) . 1, 4 One patient's diagnosis was subsequently changed to Sturge-Weber syndrome 4 because of the development of glaucoma with a facial CM. Scoliosis affected both sexes equally and did not correlate with LLD (Fisher's exact test, P ¼ .4472), suggesting improper management of LLD was not responsible. No patient reported lipomas, hypotonia, seizures, lower extremity thrombosis, or malignancy. Ten (32%) patients reported psychosocial difficulties, eg, low selfesteem, anxiety, and social discomfort, with no sex predilection. Psychosocial distress most often manifested in early adolescence but was also reported in patients as young as 6 years of age while undergoing laser therapy. Of note, 7 (23%) patients or parents of patients self-reported no overgrowth. Very mild asymmetry can be difficult to ascertain and might have been deemed unreportable, or perhaps soft tissue overgrowth improved with time.
An infant without obvious overgrowth should be given a diffuse capillary malformation diagnosis and evaluated closely for development of overgrowth until adulthood. We found no evidence of malignancy but still support Wilms tumor surveillance, especially in patients with total hemihypertrophy (overgrowth of the entire half of the body). 1, 4, 5 These findings confirm our initial conclusion that DCMO portends a favorable prognosis, but they also indicate that a clinic-based outcomes study would be useful. Long-term follow-up ensures proper diagnosis and management, especially for orthopedic complications. Patients and families should be counseled appropriately about laser treatment expectations and timing and provided with psychosocial support. 
